6TCQ
Crystal structure of the omalizumab Fab Ser81Arg and Gln83Arg light chain mutant
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I02 |
| Synchrotron site | Diamond |
| Beamline | I02 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2015-07-31 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 0.9795 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 44.033, 96.615, 103.509 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 28.077 - 2.050 |
| R-factor | 0.1759 |
| Rwork | 0.173 |
| R-free | 0.22140 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6tcm |
| RMSD bond length | 0.008 |
| RMSD bond angle | 0.954 |
| Data reduction software | MOSFLM |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.10_2155) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 28.080 | 2.110 |
| High resolution limit [Å] | 2.050 | 2.050 |
| Rmerge | 0.197 | 0.889 |
| Rpim | 0.075 | 0.466 |
| Number of reflections | 28445 | 2108 |
| <I/σ(I)> | 7.5 | 1.7 |
| Completeness [%] | 99.7 | 96.3 |
| Redundancy | 7.5 | 4.1 |
| CC(1/2) | 0.990 | 0.608 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7 | 291 | 0.1M HEPES pH7 and 20% PEG 4000. Crystals were cryoprotected with 12% PEG 400 and 17% glycerol |






